Iridian Asset Management LLC Avadel Pharmaceuticals PLC Call Options Transaction History

Iridian Asset Management LLC

  • $446 Million
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 02, 2022
SELL
$5.46 - $8.29 $468,468 - $711,281
-85,800 Closed
0 $0
Q4 2021

Feb 10, 2022
SELL
$7.34 - $11.18 $538,022 - $819,494
-73,300 Reduced 46.07%
85,800 $693,000
Q1 2020

May 11, 2020
BUY
$4.06 - $10.64 $645,945 - $1.69 Million
159,100 New
159,100 $1.26 Million

Others Institutions Holding AVDL

# of Institutions
8
Shares Held
1.07M
Call Options Held
0
Put Options Held
0
View Full List

About AVADEL PHARMACEUTICALS PLC

AVDL Quotes by TradingView
  • Ticker AVDL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 60,581,300
  • Market Cap $650M
  • Description
  • Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...
More about AVDL
Track This Portfolio

Track Iridian Asset Management LLC Portfolio

Follow Iridian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iridian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iridian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email